price to sales ratio
These three leading fast food companies continue to launch successful new menu items, which is helping them compete with smaller fast casual chains like Chipotle and Panera Bread. They are also speeding up service and improving the quality of their stores. MCDONALD’S CORP. $117 (New York symbol MCD; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 918.2 million; Market cap: $107.4 billion; Price-to-sales ratio: 4.2; Dividend yield: 3.0%; TSINetwork Rating: Above Average; www.mcdonalds.com) plans to sell 4,000 of its company-owned outlets to franchisees. As a result, franchisees will operate 93% of the chain’s 35,000 restaurants by 2018, compared to 81% today. This will lower the company’s operating expenses and free it from maintaining and upgrading these outlets. In addition, McDonald’s plans to cut $500 million a year from its administrative costs by the end of 2017....
BAXTER INTERNATIONAL INC. $39(New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 547.0 million; Market cap: $21.3 billion; Price-to-sales ratio: 2.1; Dividend yield: 1.2%; TSINetwork Rating: Average; www.baxter.com) earned $755 million, or $1.38 a share, in 2015 before unusual items. That’s up 7.5% from $702 million, or $1.28, in 2014. Revenue fell 7.0%, to $10.0 billion from $10.7 billion. However, without the negative impact of currency exchange rates, revenue gained 3%. The company continues to spend about 6% of its revenue on research. That has let it launch several successful new products, including its Sigma Spectrum pump for injecting drugs and fluids into a hospital patient. New products like this should lift Baxter’s revenue in 2016 by 3% to 4%. In addition, cost cuts will help push up earnings to $1.50 a share. The stock trades at 26.0 times that estimate. That’s an acceptable multiple, considering Baxter’s strong reputation and its high research costs. The $0.46 dividend yields 1.2%....
NORDSTROM INC. $52 (New York symbol JWN; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 173.5 million; Market cap: $9.0 billion; Price-to-sales ratio: 0.6; Dividend yield: 2.8%; TSINetwork Rating: Average; www.nordstrom.com) owns and operates 323 stores in the U.S. and Canada that mainly sell upscale clothing and footwear. Due to investments in its online business and the opening of new stores in Canada, Nordstrom’s earnings in its 2016 fiscal year, which ended January 30, 2016, fell 15.3%, to $3.15 a share from $3.72 in 2015. Sales rose 6.9%, to $14.4 billion from $13.5 billion, while same-store sales gained 2.7%. Online sales jumped 20.2%, and accounted for 19.6% of its total sales. Nordstrom is still a buy....
BAXALTA INC. $39(New York symbol BXLT; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 679.3 million; Market cap: $26.5 billion; Price-to-sales ratio: 4.3; Dividend yield: 0.7%; TSINetwork Rating: Average; www.baxalta.com) plans to merge with Ireland-based Shire (Nasdaq symbol SHPG), which makes drugs for rare and life-threatening diseases. Taken together, the companies are developing new treatments that should boost their combined annual revenue from $14 billion in 2015 to $20 billion by 2020. Plus the new firm will save $500 million a year by eliminating overlapping operations. Also, the merged company will be based in Ireland, so its income tax rate will be 16% to 17%— compared to the 23% Baxalta currently pays. Under the proposal, Baxalta investors would receive $18.00 a share in cash and 0.1482 of a Shire American depositary receipt (ADR) for each share they hold, giving them 34% of the combined company. Based on current prices, Shire’s offer is worth $41.78 per Baxalta share....
C.R. BARD INC. $194(New York symbol BCR; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 73.7 million; Market cap: $14.3 billion; Price-to-sales ratio: 4.2; Dividend yield: 0.5%; TSINetwork Rating: Above Average; www.crbard.com) has acquired Liberator Medical Holdings for $181 million. This firm distributes a variety of medical products such as urological catheters and diabetic supplies, directly to consumers’homes. Under the deal, Bard plans to expand the availability of its own medical devices. That should add $70 million to its annual sales of $3.4 billion, and $0.05 to $0.10 a share to its annual earnings in 2017; Bard will probably earn $9.97 a share in 2016. The stock trades at a reasonable 19.5 times that forecast. C.R. Bard is a buy.
Genuine Parts and Snap-On (see box) face two challenges: cyclical demand for their automotive products, and a high U.S. dollar, which is hurting the contribution of their foreign businesses. They are using the current slowdown to make small acquisitions that will open new product lines. Their cost-control plans are also freeing up more cash for dividends. GENUINE PARTS CO. $91 (New York symbol GPC; Conservative Growth and Income Portfolios, Manufacturing & Industry sector; Shares outstanding: 150.8 million; Market cap: $13.7 billion; Price-to-sales ratio: 0.9; Dividend yield: 2.9%; TSINetwork Rating: Average; www.genpt.com) gets 52% of its sales and 57% of its earnings by selling replacement auto parts: Genuine operates 1,100 outlets under the NAPA banner, and its distribution business serves 4,900 independent stores in North America, Australia and New Zealand....
FAIR ISAAC CORP. $96(New York symbol FICO; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 31.4 million; Market cap: $3.0 billion; Price-to-sales ratio: 3.5; Dividend yield: 0.1%; TSINetwork Rating: Average; www.fico.com) is best known for its FICO Scores computer program, which helps lenders make better decisions about customer creditworthiness. It also makes software that helps credit card issuers control fraud and analyze cardholders’spending patterns. The company is now applying its banking expertise to other areas of cybersecurity. It recently won a patent for a system that monitors corporate networks for suspicious activity or online attacks. It received another patent for a similar program that helps power, gas and water utilities detect unusual consumption patterns. However, the stock trades at a high 29.4 times the $3.26 a share that Fair Isaac will probably earn in its 2016 fiscal year, which ends September 30, 2016....
SNAP-ON INC. $146 (New York symbol SNA; Conservative Growth and Income Portfolios, Manufacturing & Industry sector; Shares outstanding: 58.1 million; Market cap: $8.5 billion; Price-to-sales ratio: 2.3; Dividend yield: 1.7%; TSINetwork Rating: Average; www.snapon.com) makes tools for auto mechanics and sells them through a fleet of franchised vans that visit garages. It also makes specialized tools for industrial customers. In 2015, Snap-On’s revenue gained 2.3%, to $3.4 billion from $3.3 billion in 2014. Excluding exchange rates and acquisitions, sales gained 7.1%. Earnings per share rose 13.4%, to $8.10 from $7.14. The company continues to benefit as carmakers add new features to their vehicles such as automatic parking and braking systems. That has forced repair shops to invest in new tools and upgrade their diagnostic equipment. Most of these clients borrow the funds they need to buy new tools and equipment, which has increased earnings at Snap-On’s financing division....
On July 1, 2015, Baxter International handed out 80.5% the shares in its Baxalta subsidiary to its investors on a one-for-one basis. Baxalta makes vaccines and drugs in three main areas: hematology (blood diseases), immunology (immune system) and oncology (cancer). Baxter now focuses on medical devices, such as intravenous pumps and kidney-dialysis equipment, and operating room drugs such as anesthesia. BAXTER INTERNATIONAL INC. $39 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 547.0 million; Market cap: $21.3 billion; Price-to-sales ratio: 2.1; Dividend yield: 1.2%; TSINetwork Rating: Average; www.baxter.com) earned $755 million, or $1.38 a share, in 2015 before unusual items. That’s up 7.5% from $702 million, or $1.28, in 2014. Revenue fell 7.0%, to $10.0 billion from $10.7 billion. However, without the negative impact of currency exchange rates, revenue gained 3%....
PFIZER INC. $30(New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 6.2 billion; Market cap: $186.0 billion; Price-to-sales ratio: 3.8; Dividend yield: 4.0%; TSINetwork Rating: Above Average; www.pfizer.com) acquired rival drug maker Wyeth in October 2009. Wyeth has now agreed to pay the U.S. Medicaid system $784.6 million to settle a dispute over how it calculated rebates for its Protonix acid reflux drug between 2001 and 2006. Pfizer will have to restate its earnings for 2015 to reflect this charge. However, its earnings before unusual items of $2.20 a share remains unchanged....